Suppr超能文献

[嗜铬细胞瘤患者的麻醉。我们自己的结果及综述]

[Anesthesia for patients with pheochromocytoma. Our own results and a review].

作者信息

Adams H A, Hempelmann G

机构信息

Abteilung für Anaesthesie und Intensivmedizin, Marienkrankenhaus Trier-Ehrang.

出版信息

Anasthesiol Intensivmed Notfallmed Schmerzther. 1993 Dec;28(8):500-9. doi: 10.1055/s-2007-998971.

Abstract

Phaeochromocytoma is a rare, autonomous catecholamine secreting tumour of the sympatho-adrenergic system. Due to the continuous or phasic secretion of catecholamines from the tumour, patients present with hypertensive crisis, episodic or sustained hypertension or arrhythmia. Excessive intraoperative hypertension unable to control by usual methods should be considered to be a phaeochromocytoma. Surgical removal of identified lesions should be performed under controlled conditions and after sufficient preparation of the patient. Preoperative alpha-adrenergic blockade with prazosin and phentolamine allows an increase in intravascular volume and affords some protection against excessive intraoperative hypertension. The use of beta-adrenergic antagonists is only recommended in patients with arrhythmia (especially tachycardia) and after induction of alpha-adrenergic blockade. For operation of phaeochromocytoma, modified neuroleptic anaesthesia is a useful anaesthetic technique. Intraoperative hypertension is controlled with sodium nitroprusside and phentolamine. Intravascular volume is substituted under CVP or PAP control, and epinephrine or norepinephrine are used if necessary. During the postoperative period, hypotension or hypertension or left ventricular failure may occur. In an own study, 9 patients with phaeochromocytoma were investigated, 7 patients with other operations of the adrenal glands served as controls. Despite specific preoperative preparation and intraoperative use of antihypertensive drugs, excessive increases in blood pressure could not be avoided in some cases. Extremely high plasma levels of catecholamines up to the factor 1,000 of the normal range were found. Even in controls, considerable increases in blood pressure and catecholamine levels were observed.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

嗜铬细胞瘤是一种罕见的、自主分泌儿茶酚胺的交感 - 肾上腺素能系统肿瘤。由于肿瘤持续或间歇性分泌儿茶酚胺,患者会出现高血压危象、发作性或持续性高血压或心律失常。术中常规方法无法控制的过度高血压应考虑为嗜铬细胞瘤。应在可控条件下并在患者充分准备后对已确定的病变进行手术切除。术前使用哌唑嗪和酚妥拉明进行α - 肾上腺素能阻滞可增加血管内容量,并为防止术中过度高血压提供一定保护。仅在有心律失常(尤其是心动过速)的患者以及在诱导α - 肾上腺素能阻滞后才推荐使用β - 肾上腺素能拮抗剂。对于嗜铬细胞瘤手术,改良的神经安定麻醉是一种有用的麻醉技术。术中高血压用硝普钠和酚妥拉明控制。在中心静脉压(CVP)或肺动脉压(PAP)监测下补充血管内容量,必要时使用肾上腺素或去甲肾上腺素。术后可能会发生低血压、高血压或左心室衰竭。在一项自身研究中,对9例嗜铬细胞瘤患者进行了调查,7例接受其他肾上腺手术的患者作为对照。尽管进行了特定的术前准备并在术中使用了抗高血压药物,但在某些情况下仍无法避免血压过度升高。发现血浆儿茶酚胺水平极高,高达正常范围的1000倍。即使在对照组中,也观察到血压和儿茶酚胺水平有相当大的升高。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验